We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Pfizer CDR CAD Hedged | NEO:PFE | NEO | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.04 | -0.34% | 11.82 | 11.68 | 11.90 | 11.94 | 11.79 | 11.92 | 85,856 | 22:30:01 |
From Feb 2023 to Feb 2025
9:58 ET--Pfizer is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The drugmaker issued 2024 guidance that fell short of Wall Street's expectations and warned that revenue could decline next year amid a continued slowdown in demand for its Covid-19 vaccine and related products. Pfizer shares fall more than 9% and hit a 52-week low. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
December 13, 2023 10:13 ET (15:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Pfizer CDR CAD Hedged Chart |
1 Month Pfizer CDR CAD Hedged Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
